ESSENTIAL THROMBOCYTHEMIA
Clinical trials for ESSENTIAL THROMBOCYTHEMIA explained in plain language.
Never miss a new study
Get alerted when new ESSENTIAL THROMBOCYTHEMIA trials appear
Sign up with your email to follow new studies for ESSENTIAL THROMBOCYTHEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood clot risk in rare disease: could a higher dose of clopidogrel offer better protection?
Disease control Not yet recruitingThis study looks at whether a higher dose of the blood thinner clopidogrel works better for people with essential thrombocythemia (ET), a rare blood disorder that raises the risk of dangerous blood clots. The standard dose may not work well for many ET patients, so researchers wi…
Matched conditions: ESSENTIAL THROMBOCYTHEMIA
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for rare blood cancer: targeted drug enters final testing
Disease control Not yet recruitingThis study tests a new drug, INCA033989, against the best current treatments for people with a rare blood cancer called essential thrombocythemia who have a specific gene mutation (CALR). About 426 adults who have already tried at least one prior therapy will be randomly assigned…
Matched conditions: ESSENTIAL THROMBOCYTHEMIA
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New oral drug could tame overactive bone marrow in rare blood cancers
Disease control Not yet recruitingThis study tests a pill called selinexor in 15 adults with chronic blood cancers (MPN) whose blood cell counts are too high. The goal is to see if selinexor can safely bring those counts down and ease symptoms. Participants take the drug once a week for up to 3 months and are fol…
Matched conditions: ESSENTIAL THROMBOCYTHEMIA
Phase: PHASE2 • Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC